You have searched for "competition"
Showing 1-10 of 10000
N its early stages, the Malaysia Competition Commission (MyCC) conducted numerous briefings for enterprises and associations, highlighting the implications of the Competition Act 2010 (CA) on their activities. A moratorium of 18 months was given for all to review their activities to ensure compliance with the new law.
THE Competition Act 2010 (CA 2010) has been in force for over a year, and yet there are still a large number of businesses that are not complying with its provisions. Is this because they do not understand how it applies to their businesses or is it because they are part of an even larger number that still do not know of its existence. Either way, the Malaysia Competition Commission (MyCC) is concerned.
IN the last CompEtition Opinion (StarBiz, March 11), the Malaysia Competition Commission (MyCC) expressed concern about the number of Malaysian businesses that were either not aware of the Competition Act 2010 (CA 2010) or were still not complying with its terms, even though it had been in force since Jan 1, 2012.
SINGAPORE: Singapore's competition watchdog said on Friday that it had reasonable grounds for suspecting competition had been infringed by the agreed deal by ride-hailing firm Uber Technologies Inc to sell its Southeast Asia operations to rival Grab.
The Malaysia Competition Commission (MyCC), which ensures healthy competition in the Malaysian market, has ruled in its proposed decision that Malaysian Airline and AirAsia’s 2011 collaboration agreement violated the Competition Act 2010, and fined each company RM10mil.
KUALA LUMPUR: Fitch Ratings expects Telekom Malaysia Bhd (TM, A-/Stable) to face higher competition in the fast-growing, increasingly important data segment in 2013, especially from the "resellers".
SINGAPORE: The Competition and Consumer Commission of Singapore (CCCS) has issued interim measures to stall Grab's takeover of Uber operations here.
The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.